Cargando…
A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease
Cellular replacement therapy using mesenchymal stem cells (MSCs) and/or the delivery of growth factors are at the forefront of minimally invasive biological treatment options for Degenerative Disc Disease (DDD). In this study, we compared the therapeutic potential of a novel drug candidate, NTG-101...
Autores principales: | Matta, Ajay, Karim, Muhammad Zia, Gerami, Hoda, Benigno, Bettina, Erwin, W. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292352/ https://www.ncbi.nlm.nih.gov/pubmed/34285277 http://dx.doi.org/10.1038/s41598-021-94173-w |
Ejemplares similares
-
A Single Injection of NTG-101 Reduces the Expression of Pain-Related Neurotrophins in a Canine Model of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2022) -
NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2018) -
Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus
por: Matta, Ajay, et al.
Publicado: (2017) -
Injectable Biologics for the Treatment of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2020) -
The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc
por: Erwin, William Mark, et al.
Publicado: (2015)